Neonode (NEON) vs Niki BioSolutions (NIKI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Neonode (NEON) has outperformed Niki BioSolutions (NIKI) over the past year, losing 78.1% versus a loss of 83.1%. Over five years, NEON leads with a -89.8% price change compared with -98.5% for NIKI. Neonode is the larger company by market cap ($14.1 million vs $12.5 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NEON | NIKI |
|---|---|---|
| Share price | $0.838 | $4.00 |
| Market cap | $14.06M | $12.47M |
| 1-day change | -4.78% | -7.41% |
| YTD return | -51.84% | -62.26% |
| 1-year return | -78.06% | -83.12% |
| 5-year return | -89.84% | -98.46% |
| P/E ratio (TTM) | 1.86 | — |
| EPS (TTM) | $0.45 | $-2.69 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.70 | $17.60 |
| 52-week low | $0.72 | $4.00 |
| Distance from 52-week high | -77.35% | -77.27% |
| Average volume | 77.32K | 160.00K |
| Shares outstanding | 16.78M | 2.94M |
| Employees | 35 | 1 |
| Sector | Technology | Industrials |
| Industry | Industrial Machinery/Components | Industrial Machinery/Components |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: Neonode in Technology and Niki BioSolutions in Industrials.
About Neonode
NEON stock →Neonode Inc., together with its subsidiaries, provides software solutions for machine perception to detect and track persons and objects in video streams from cameras and other types of imagers in the United States, Japan, South Korea, Germany, Sweden, China, and internationally. It also offers optical sensing solutions for contactless touch, touch, and gesture sensing.
Technology · Industrial Machinery/Components · 35 employees
About Niki BioSolutions
NIKI stock →Niki BioSolutions, Inc., through its subsidiaries, operates as a clinical-stage biopharmaceutical company and engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases. Its pipeline products include SACT-1, a repurposed drug candidate, which is in a Phase 1 clinical trial to treat neuroblastoma and other cancer types; ALS-4, a repurposed small molecule, which is in a Phase 1 clinical trial for the treatment of bacterial infections, such as staphylococcus aureus, mycobacterium tuberculosis, and pseudomonas aeruginosa.
Industrials · Industrial Machinery/Components · 1 employees
NEON vs NIKI FAQ
Which is bigger, Neonode or Niki BioSolutions?
Neonode (NEON) is larger, with a market capitalization of $14.06M compared with $12.47M for Niki BioSolutions (NIKI).
Which stock has performed better over the past year, NEON or NIKI?
NEON returned -78.06% over the past 12 months, compared with -83.12% for NIKI (price return, excluding dividends). Past performance does not predict future results.
Are Neonode and Niki BioSolutions in the same industry?
Yes. Both are classified in the Industrial Machinery/Components industry within the Technology sector.